Liquidia LQDA
NASDAQ LQDA
$68.73 +1.05 (+1.55%)
As of: Sep 9, 2026 · 3:12 PM EDT

Liquidia (LQDA) Change in Accured Expenses (2020 - 2026)

Liquidia (LQDA) posted Change in Accured Expenses of $34.0 million for Q2 2026, up 133.76% on a QoQ basis from $14.5 million in Q1 2026, and up 291.31% year-over-year from $8.7 million in Q2 2025.

Analysis

Liquidia (LQDA) Change in Accured Expenses (2020 - 2026) Analysis & Trends

Liquidia has reported Change in Accured Expenses for 7 years, with the latest figure at $34.0 million in Q2 2026.

  • On a quarterly basis, Change in Accured Expenses rose 291.31% year-over-year to $34.0 million in Q2 2026; TTM through Jun 2026 was $99.2 million, a 952.61% increase from a year earlier, with the FY2025 full-year figure at $54.5 million, up 937.04% from the prior year.
  • Change in Accured Expenses was $34.0 million for Q2 2026 at Liquidia, up from $14.5 million in the prior quarter.
  • The five-year high for Change in Accured Expenses was $34.0 million in Q2 2026, with the low at -$4.8 million in Q1 2025.
  • Average Change in Accured Expenses over 5 years is $6.5 million, with a median of $1.8 million recorded in 2023.
  • The largest YoY upside for Change in Accured Expenses was 1913.33% in 2023 against a maximum downside of 3781.43% in 2023.
  • Over 5 years, Change in Accured Expenses stood at $330000.0 in 2022, then soared by 1913.33% to $6.6 million in 2023, then slumped by 70.38% to $2.0 million in 2024, then jumped by 1564.28% to $32.8 million in 2025, then grew by 3.72% to $34.0 million in 2026.
  • The last three Change in Accured Expenses figures came in at $34.0 million (Q2 2026), $14.5 million (Q1 2026), and $32.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Johnson & Johnson 646.43 Bn 625.67 Bn 17.26 Bn 2.32 Bn
2 AbbVie 442.46 Bn 435.89 Bn 12.70 Bn 1.20 Bn
3 Merck 366.77 Bn 359.63 Bn 12.21 Bn -
4 Novartis Ag 266.59 Bn 258.90 Bn 11.24 Bn -
5 Pfizer 159.14 Bn 147.45 Bn 10.94 Bn -
6 Sanofi 52.40 Bn 45.02 Bn 10.79 Bn -
7 Revolution Medicines 44.08 Bn 44.08 Bn - 55.78 Mn
8 Incyte 25.38 Bn 20.85 Bn 1.57 Bn -204.33 Mn
9 United Therapeutics 21.53 Bn 18.87 Bn 683.80 Mn -4.00 Mn
10 Liquidia 6.11 Bn 5.82 Bn 160.92 Mn 33.97 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.97 Mn
Mar 31, 2026 14.53 Mn
Dec 31, 2025 32.75 Mn
Sep 30, 2025 17.92 Mn
Jun 30, 2025 8.68 Mn
Mar 31, 2025 -4.82 Mn
Dec 31, 2024 1.97 Mn
Sep 30, 2024 3.59 Mn
Jun 30, 2024 -968,000.00
Mar 31, 2024 668,000.00
Dec 31, 2023 6.64 Mn
Sep 30, 2023 1.86 Mn
Jun 30, 2023 1.82 Mn
Mar 31, 2023 -2.58 Mn
Dec 31, 2022 330,000.00
Sep 30, 2022 936,000.00
Jun 30, 2022 -791,000.00
Mar 31, 2022 70,000.00
Dec 31, 2021 790,000.00
Sep 30, 2021 1.01 Mn